↓ Skip to main content

Dove Medical Press

Cetuximab: its unique place in head and neck cancer treatment

Overview of attention for article published in Biologics: Targets & Therapy, April 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
3 patents

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
122 Mendeley
Title
Cetuximab: its unique place in head and neck cancer treatment
Published in
Biologics: Targets & Therapy, April 2013
DOI 10.2147/btt.s43628
Pubmed ID
Authors

Pol Specenier, Jan B Vermorken

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
Tanzania, United Republic of 1 <1%
Switzerland 1 <1%
Spain 1 <1%
Chile 1 <1%
Unknown 116 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 27 22%
Student > Master 17 14%
Student > Bachelor 16 13%
Researcher 12 10%
Student > Doctoral Student 11 9%
Other 18 15%
Unknown 21 17%
Readers by discipline Count As %
Medicine and Dentistry 49 40%
Agricultural and Biological Sciences 17 14%
Biochemistry, Genetics and Molecular Biology 13 11%
Immunology and Microbiology 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 11 9%
Unknown 24 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2021.
All research outputs
#8,616,072
of 25,576,801 outputs
Outputs from Biologics: Targets & Therapy
#108
of 274 outputs
Outputs of similar age
#72,700
of 213,426 outputs
Outputs of similar age from Biologics: Targets & Therapy
#5
of 6 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 274 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,426 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.